Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2012-09-06 21:03:00 UTC |
---|
Update Date | 2021-09-14 15:46:19 UTC |
---|
HMDB ID | HMDB0028922 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Leucylalanine |
---|
Description | Leucylalanine, also known as L-A or leu-ala, belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. Leucylalanine has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make leucylalanine a potential biomarker for the consumption of these foods. Leucylalanine is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a significant number of articles have been published on Leucylalanine. |
---|
Structure | CC(C)C[C@H](N)C(=O)N[C@@H](C)C(O)=O InChI=1S/C9H18N2O3/c1-5(2)4-7(10)8(12)11-6(3)9(13)14/h5-7H,4,10H2,1-3H3,(H,11,12)(H,13,14)/t6-,7-/m0/s1 |
---|
Synonyms | Value | Source |
---|
L-A | ChEBI | L-Leu-L-ala | ChEBI | LA | ChEBI | Leucyl-alanine | HMDB | L-a Dipeptide | HMDB | L-Leucyl-L-alanine | HMDB | LA dipeptide | HMDB | Leu-ala | HMDB | Leucine alanine dipeptide | HMDB | Leucine-alanine dipeptide | HMDB | N-L-Leucyl-L-alanine | HMDB | N-Leucylalanine | HMDB | Leucylalanine | ChEBI |
|
---|
Chemical Formula | C9H18N2O3 |
---|
Average Molecular Weight | 202.254 |
---|
Monoisotopic Molecular Weight | 202.131742448 |
---|
IUPAC Name | (2S)-2-[(2S)-2-amino-4-methylpentanamido]propanoic acid |
---|
Traditional Name | (2S)-2-[(2S)-2-amino-4-methylpentanamido]propanoic acid |
---|
CAS Registry Number | 7298-84-2 |
---|
SMILES | CC(C)C[C@H](N)C(=O)N[C@@H](C)C(O)=O |
---|
InChI Identifier | InChI=1S/C9H18N2O3/c1-5(2)4-7(10)8(12)11-6(3)9(13)14/h5-7H,4,10H2,1-3H3,(H,11,12)(H,13,14)/t6-,7-/m0/s1 |
---|
InChI Key | HSQGMTRYSIHDAC-BQBZGAKWSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Peptides |
---|
Alternative Parents | |
---|
Substituents | - Alpha peptide
- N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Alanine or derivatives
- Alpha-amino acid or derivatives
- Amino acid or derivatives
- Amino acid
- Carboximidic acid
- Carboximidic acid derivative
- Carboxylic acid
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Primary aliphatic amine
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Amine
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | -2.13 | Extrapolated |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 153.092 | 30932474 | DeepCCS | [M-H]- | 150.734 | 30932474 | DeepCCS | [M-2H]- | 183.651 | 30932474 | DeepCCS | [M+Na]+ | 159.185 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Leucylalanine,1TMS,isomer #1 | CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C | 1689.2 | Semi standard non polar | 33892256 | Leucylalanine,1TMS,isomer #2 | CC(C)C[C@H](N[Si](C)(C)C)C(=O)N[C@@H](C)C(=O)O | 1709.4 | Semi standard non polar | 33892256 | Leucylalanine,1TMS,isomer #3 | CC(C)C[C@H](N)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C | 1698.4 | Semi standard non polar | 33892256 | Leucylalanine,2TMS,isomer #1 | CC(C)C[C@H](N[Si](C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C | 1769.6 | Semi standard non polar | 33892256 | Leucylalanine,2TMS,isomer #1 | CC(C)C[C@H](N[Si](C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C | 1737.6 | Standard non polar | 33892256 | Leucylalanine,2TMS,isomer #2 | CC(C)C[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1693.9 | Semi standard non polar | 33892256 | Leucylalanine,2TMS,isomer #2 | CC(C)C[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1767.3 | Standard non polar | 33892256 | Leucylalanine,2TMS,isomer #3 | CC(C)C[C@@H](C(=O)N[C@@H](C)C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1879.4 | Semi standard non polar | 33892256 | Leucylalanine,2TMS,isomer #3 | CC(C)C[C@@H](C(=O)N[C@@H](C)C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1779.1 | Standard non polar | 33892256 | Leucylalanine,2TMS,isomer #4 | CC(C)C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C | 1762.4 | Semi standard non polar | 33892256 | Leucylalanine,2TMS,isomer #4 | CC(C)C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C | 1764.7 | Standard non polar | 33892256 | Leucylalanine,3TMS,isomer #1 | CC(C)C[C@@H](C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1890.6 | Semi standard non polar | 33892256 | Leucylalanine,3TMS,isomer #1 | CC(C)C[C@@H](C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1876.5 | Standard non polar | 33892256 | Leucylalanine,3TMS,isomer #2 | CC(C)C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1769.4 | Semi standard non polar | 33892256 | Leucylalanine,3TMS,isomer #2 | CC(C)C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1848.6 | Standard non polar | 33892256 | Leucylalanine,3TMS,isomer #3 | CC(C)C[C@@H](C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1895.6 | Semi standard non polar | 33892256 | Leucylalanine,3TMS,isomer #3 | CC(C)C[C@@H](C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1906.8 | Standard non polar | 33892256 | Leucylalanine,4TMS,isomer #1 | CC(C)C[C@@H](C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1958.8 | Semi standard non polar | 33892256 | Leucylalanine,4TMS,isomer #1 | CC(C)C[C@@H](C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1992.6 | Standard non polar | 33892256 | Leucylalanine,1TBDMS,isomer #1 | CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C | 1933.1 | Semi standard non polar | 33892256 | Leucylalanine,1TBDMS,isomer #2 | CC(C)C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O | 1950.5 | Semi standard non polar | 33892256 | Leucylalanine,1TBDMS,isomer #3 | CC(C)C[C@H](N)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C | 1911.8 | Semi standard non polar | 33892256 | Leucylalanine,2TBDMS,isomer #1 | CC(C)C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C | 2209.5 | Semi standard non polar | 33892256 | Leucylalanine,2TBDMS,isomer #1 | CC(C)C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C | 2149.4 | Standard non polar | 33892256 | Leucylalanine,2TBDMS,isomer #2 | CC(C)C[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2157.2 | Semi standard non polar | 33892256 | Leucylalanine,2TBDMS,isomer #2 | CC(C)C[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2179.6 | Standard non polar | 33892256 | Leucylalanine,2TBDMS,isomer #3 | CC(C)C[C@@H](C(=O)N[C@@H](C)C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2324.7 | Semi standard non polar | 33892256 | Leucylalanine,2TBDMS,isomer #3 | CC(C)C[C@@H](C(=O)N[C@@H](C)C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2179.5 | Standard non polar | 33892256 | Leucylalanine,2TBDMS,isomer #4 | CC(C)C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C | 2228.4 | Semi standard non polar | 33892256 | Leucylalanine,2TBDMS,isomer #4 | CC(C)C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C | 2160.4 | Standard non polar | 33892256 | Leucylalanine,3TBDMS,isomer #1 | CC(C)C[C@@H](C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2571.7 | Semi standard non polar | 33892256 | Leucylalanine,3TBDMS,isomer #1 | CC(C)C[C@@H](C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2446.3 | Standard non polar | 33892256 | Leucylalanine,3TBDMS,isomer #2 | CC(C)C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2442.7 | Semi standard non polar | 33892256 | Leucylalanine,3TBDMS,isomer #2 | CC(C)C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2418.6 | Standard non polar | 33892256 | Leucylalanine,3TBDMS,isomer #3 | CC(C)C[C@@H](C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2569.7 | Semi standard non polar | 33892256 | Leucylalanine,3TBDMS,isomer #3 | CC(C)C[C@@H](C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2465.5 | Standard non polar | 33892256 | Leucylalanine,4TBDMS,isomer #1 | CC(C)C[C@@H](C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2807.6 | Semi standard non polar | 33892256 | Leucylalanine,4TBDMS,isomer #1 | CC(C)C[C@@H](C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2713.0 | Standard non polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Leucylalanine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Leucylalanine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Leucylalanine 10V, Positive-QTOF | splash10-000i-9000000000-57e0bc673db843b68262 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Leucylalanine 20V, Positive-QTOF | splash10-000i-9000000000-9c4912711fb5a72ff0af | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Leucylalanine 30V, Positive-QTOF | splash10-000f-9000000000-8be29611742df0f89b93 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Leucylalanine 10V, Positive-QTOF | splash10-000i-9000000000-d92d725b01e578391565 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Leucylalanine 0V, Positive-QTOF | splash10-0udi-0090000000-358cb5d4b4dd0c6d88cc | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Leucylalanine 10V, Positive-QTOF | splash10-000i-9000000000-0bdb165d61ab4962274b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Leucylalanine 0V, Positive-QTOF | splash10-0udi-0090000000-a6bcb8f1301ab785fed3 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Leucylalanine 30V, Positive-QTOF | splash10-0006-9000000000-4127196646bcae50ad93 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Leucylalanine 40V, Positive-QTOF | splash10-0006-9000000000-66ae66e55829c4899839 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Leucylalanine 30V, Positive-QTOF | splash10-000f-9000000000-8ec0b8f50a926835df3e | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Leucylalanine 10V, Negative-QTOF | splash10-0ue9-2490000000-9dc3cdf47b7f35ad1da1 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Leucylalanine 20V, Negative-QTOF | splash10-000i-9300000000-ede4d25762039e20c4dc | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Leucylalanine 40V, Negative-QTOF | splash10-0006-9000000000-82997a4bb57177bf4d3e | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Leucylalanine 10V, Positive-QTOF | splash10-0f7c-9130000000-df48a48f5ba316cbd00f | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Leucylalanine 20V, Positive-QTOF | splash10-00ko-9000000000-447eefe2d6f7b170e647 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Leucylalanine 40V, Positive-QTOF | splash10-00kf-9000000000-6aac4c77322775945124 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB111950 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 73739 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 81721 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 73527 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Hong L, Turner RT 3rd, Koelsch G, Shin D, Ghosh AK, Tang J: Crystal structure of memapsin 2 (beta-secretase) in complex with an inhibitor OM00-3. Biochemistry. 2002 Sep 10;41(36):10963-7. [PubMed:12206667 ]
- Nath M, Pokharia S, Eng G, Song X, Kumar A: New triorganotin (IV) derivatives of dipeptides as models for metal-protein interactions: synthesis, structural characterization and biological studies. Spectrochim Acta A Mol Biomol Spectrosc. 2006 Jan;63(1):66-75. Epub 2005 Jun 9. [PubMed:15950528 ]
- Wang T, Simbulan-Rosenthal CM, Smulson ME, Chock PB, Yang DC: Polyubiquitylation of PARP-1 through ubiquitin K48 is modulated by activated DNA, NAD+, and dipeptides. J Cell Biochem. 2008 May 1;104(1):318-28. [PubMed:18041763 ]
- Kilic N, Kustimur S, Arslan S, Aldemir H: Fluorometric determination of acid proteinase activity in vulvovaginal candidosis. Mycoses. 1996 Sep-Oct;39(9-10):347-51. [PubMed:9009656 ]
- Krishnakumar SS, London E: Effect of sequence hydrophobicity and bilayer width upon the minimum length required for the formation of transmembrane helices in membranes. J Mol Biol. 2007 Nov 30;374(3):671-87. Epub 2007 Sep 20. [PubMed:17950311 ]
- Bedner M, MacCrehan WA, Helz GR: Making chlorine greener: investigation of alternatives to sulfite for dechlorination. Water Res. 2004 May;38(10):2505-14. [PubMed:15159154 ]
- Turner RT 3rd, Koelsch G, Hong L, Castanheira P, Ermolieff J, Ghosh AK, Tang J: Subsite specificity of memapsin 2 (beta-secretase): implications for inhibitor design. Biochemistry. 2001 Aug 28;40(34):10001-6. [PubMed:11513577 ]
|
---|